These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30815751)

  • 1. Emerging Therapeutics for Ocular Surface Disease.
    Bielory L; Schoenberg D
    Curr Allergy Asthma Rep; 2019 Feb; 19(3):16. PubMed ID: 30815751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of nonpharmacologic treatments for acute seasonal allergic conjunctivitis.
    Bilkhu PS; Wolffsohn JS; Naroo SA; Robertson L; Kennedy R
    Ophthalmology; 2014 Jan; 121(1):72-78. PubMed ID: 24070810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic and clinical factors associated with development of brimonidine tartrate 0.2%-induced ocular allergy.
    Manni G; Centofanti M; Sacchetti M; Oddone F; Bonini S; Parravano M; Bucci MG
    J Glaucoma; 2004 Apr; 13(2):163-7. PubMed ID: 15097264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options in ocular allergic disease.
    Hingorani M; Lightman S
    Drugs; 1995 Aug; 50(2):208-21. PubMed ID: 8521755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-inflammatory effects of therapies for ocular allergy.
    Mantelli F; Calder VL; Bonini S
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):786-93. PubMed ID: 24044620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
    Crampton HJ
    Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic Conjunctivitis Management: Update on Ophthalmic Solutions.
    Leonardi A; Quintieri L; Presa IJ; LLoves JM; Montero J; Benítez-Del-Castillo JM; Lestón FJS; González-Mancebo E; Asero R; Groblewska A; Kuna P
    Curr Allergy Asthma Rep; 2024 Jul; 24(7):347-360. PubMed ID: 38869807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing and managing allergic conjunctivitis in childhood: The allergist's perspective.
    Fauquert JL
    Pediatr Allergy Immunol; 2019 Jun; 30(4):405-414. PubMed ID: 30742722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis.
    Abelson MB; Turner D
    Clin Ther; 2003 Mar; 25(3):931-47. PubMed ID: 12852709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal and perennial allergic conjunctivitis.
    Wong AH; Barg SS; Leung AK
    Recent Pat Inflamm Allergy Drug Discov; 2014; 8(2):139-53. PubMed ID: 25000933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in pharmacotherapy for allergic conjunctivitis.
    Abelson MB; Shetty S; Korchak M; Butrus SI; Smith LM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1219-31. PubMed ID: 25943976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic conjunctivitis: a comprehensive review of the literature.
    La Rosa M; Lionetti E; Reibaldi M; Russo A; Longo A; Leonardi S; Tomarchio S; Avitabile T; Reibaldi A
    Ital J Pediatr; 2013 Mar; 39():18. PubMed ID: 23497516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seasonal and perennial allergic rhinoconjunctivitis].
    Schröder K; Finis D; Meller S; Buhren BA; Wagenmann M; Geerling G
    Klin Monbl Augenheilkd; 2014 May; 231(5):496-504. PubMed ID: 24799168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
    Spangler DL; Abelson MB; Ober A; Gotnes PJ
    Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
    Brodsky M; Berger WE; Butrus S; Epstein AB; Irkec M
    Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
    Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution, 0.025% for Treatment of Ocular Redness.
    Torkildsen GL; Sanfilippo CM; DeCory HH; Gomes PJ
    Curr Eye Res; 2018 Jan; 43(1):43-51. PubMed ID: 29120262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fundamental Aspects and Relevance of Components in Antihistamine Eye Drops.
    Herrero-Vanrell R; Jáuregui Presa I; Leceta Bilbao A; Montero-Iruzubieta J
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):431-438. PubMed ID: 38095492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
    Ben-Eli H; Solomon A
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):411-416. PubMed ID: 30020258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.